BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24695474)

  • 1. Broth microdilution methods using B-lactamase inhibitors for the identification of Klebsiella pneumoniae carbapenemases and metallo-β-lactamases in Gram-negative bacilli.
    Jeong SH; Song W; Bae IK; Kim HS; Kim JS; Park MJ; Shin DH
    Ann Clin Lab Sci; 2014; 44(1):49-55. PubMed ID: 24695474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
    Galani I; Souli M; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Antoniadou A;
    Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1143-1150. PubMed ID: 30825054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of four different agar plate methods for rectal swabs, synergy disk tests and metallo-β-lactamase Etest for clinical isolates in detecting carbapenemase-producing Klebsiella pneumoniae.
    Papadimitriou-Olivgeris M; Vamvakopoulou S; Spyropoulou Α; Bartzavali C; Marangos M; Anastassiou ED; Spiliopoulou I; Christofidou M
    J Med Microbiol; 2016 Sep; 65(9):954-961. PubMed ID: 27452448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a new spectrophotometric assay for rapid detection and differentiation of KPC, MBL and OXA-48 carbapenemase-producing Klebsiella pneumoniae clinical isolates.
    Routsias JG; Tsakogiannis D; Katsiki M; Marinou D; Mavrouli M; Vrioni G; Tsakris A
    Int J Antimicrob Agents; 2020 Dec; 56(6):106211. PubMed ID: 33172591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae.
    Papp-Wallace KM; Barnes MD; Alsop J; Taracila MA; Bethel CR; Becka SA; van Duin D; Kreiswirth BN; Kaye KS; Bonomo RA
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem/relebactam activity compared to other antimicrobials against non-MBL-producing carbapenem-resistant Enterobacteriaceae from an academic medical center.
    Kulengowski B; Burgess DS
    Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31365075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disk Carbapenemase Test for the Rapid Detection of KPC-, NDM-, and Other Metallo-β-Lactamase-Producing Gram-Negative Bacilli.
    Kim H; Sung JY; Yong D; Jeong SH; Song W; Lee K; Chong Y
    Ann Lab Med; 2016 Sep; 36(5):434-40. PubMed ID: 27374708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae.
    Castanheira M; Rhomberg PR; Flamm RK; Jones RN
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5454-8. PubMed ID: 27381386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combined disc method with resazurin agar plate assay for early phenotypic screening of KPC, MBL and OXA-48 carbapenemases among Enterobacteriaceae.
    Teethaisong Y; Eumkeb G; Nakouti I; Evans K; Hobbs G
    J Appl Microbiol; 2016 Aug; 121(2):408-14. PubMed ID: 27253907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of MIC and disk diffusion quality control guidelines for meropenem-vaborbactam, a novel carbapenem/boronic acid β-lactamase inhibitor combination.
    Munson E; Huband MD; Castanheira M; Fedler KA; Flamm RK
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):324-328. PubMed ID: 29276104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characterization of carbapenem non-susceptible gram-negative bacilli isolated from clinical specimens.
    Abdeta A; Bitew A; Fentaw S; Tsige E; Assefa D; Lejisa T; Kefyalew Y; Tigabu E; Evans M
    PLoS One; 2021; 16(12):e0256556. PubMed ID: 34855767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of EDTA- and DPA-Based Microdilution Phenotypic Tests for the Detection of MCR-Mediated Colistin Resistance in Enterobacteriaceae.
    Büdel T; Clément M; Bernasconi OJ; Principe L; Perreten V; Luzzaro F; Endimiani A
    Microb Drug Resist; 2019 May; 25(4):494-500. PubMed ID: 30431401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Evaluation of a Novel Protein-Based Assay for Specific Detection of KPC β-Lactamases from Klebsiella pneumoniae Clinical Isolates.
    Lu S; Soeung V; Nguyen HAT; Long SW; Musser JM; Palzkill T
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
    Chen AY; Thomas PW; Stewart AC; Bergstrom A; Cheng Z; Miller C; Bethel CR; Marshall SH; Credille CV; Riley CL; Page RC; Bonomo RA; Crowder MW; Tierney DL; Fast W; Cohen SM
    J Med Chem; 2017 Sep; 60(17):7267-7283. PubMed ID: 28809565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
    Schnaars C; Kildahl-Andersen G; Prandina A; Popal R; Radix S; Le Borgne M; Gjøen T; Andresen AMS; Heikal A; Økstad OA; Fröhlich C; Samuelsen Ø; Lauksund S; Jordheim LP; Rongved P; Åstrand OAH
    ACS Infect Dis; 2018 Sep; 4(9):1407-1422. PubMed ID: 30022668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential inhibitors for
    Malathi K; Anbarasu A; Ramaiah S
    J Biomol Struct Dyn; 2019 Oct; 37(17):4601-4613. PubMed ID: 30632921
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of inhibitor-combination mCIM for detecting MBL-producing
    Yamada K; Sasaki M; Imai W; Murakami H; Morita T; Aoki K; Ishii Y; Tateda K
    J Med Microbiol; 2019 Nov; 68(11):1604-1606. PubMed ID: 31513006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of meropenem combined with vaborbactam against KPC-producing Enterobacteriaceae in China.
    Zhou M; Yang Q; Lomovskaya O; Sun D; Kudinha T; Xu Z; Zhang G; Chen X; Xu Y
    J Antimicrob Chemother; 2018 Oct; 73(10):2789-2796. PubMed ID: 29982437
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hackel MA; Lomovskaya O; Dudley MN; Karlowsky JA; Sahm DF
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance.
    van Haren MJ; Tehrani KHME; Kotsogianni I; Wade N; Brüchle NC; Mashayekhi V; Martin NI
    Chemistry; 2021 Feb; 27(11):3806-3811. PubMed ID: 33237604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.